[1]慈书俊,梁 惠,吴宁波,等.升阳除湿防风汤联合化疗治疗晚期胃癌疗效及对患者血清CA72-4、sICAM-1的影响[J].陕西中医,2024,(6):775-779.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.011]
　CI Shujun,LIANG Hui,WU Ningbo,et al.Clinical effect of Shengyang Chushi Fangfeng decoction combined with chemotherapy on advanced gastric cancer and changes of serum CA72-4 and sICAM-1[J].,2024,(6):775-779.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.011]
点击复制

升阳除湿防风汤联合化疗治疗晚期胃癌疗效及对患者血清CA72-4、sICAM-1的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
775-779
栏目:
临床研究
出版日期:
2024-06-05

文章信息/Info

Title:
Clinical effect of Shengyang Chushi Fangfeng decoction combined with chemotherapy on advanced gastric cancer and changes of serum CA72-4 and sICAM-1
作者:
慈书俊; 梁 惠; 吴宁波; 耿亚迪
(六安市中医院,安徽 六安 237006)
Author(s):
CI Shujun; LIANG Hui; WU Ningbo; GENG Yadi
(Lu'an Hospital of Traditional Chinese Medicine,Lu'an 237006,China)
关键词:
胃癌;  升阳除湿防风汤;  多西他赛;  顺铂;  5-氟尿嘧啶;  糖类抗原72-4;  可溶性细胞间黏附分子-1
Keywords:
Gastric cancer;  Shengyang Chushi Fangfeng decoction;  Docetaxel;  Cisplatin;  5-fluorouracil;  Carbohydrate antigen 72-4;  Soluble intercellular adhesion molecule-1
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7369.2024.06.011
文献标志码:
A
摘要:
目的:观察升阳除湿防风汤联合化疗治疗晚期胃癌患者的临床疗效及血清糖类抗原72-4(CA72-4)、可溶性细胞间黏附分子-1(sICAM-1)变化。方法:选择86例晚期胃癌患者,根据治疗方法将其分为两组,各43例,化疗组给予常规化疗治疗,观察组在化疗组基础上给予升阳除湿防风汤治疗,比较两组客观缓解率(ORR)、疾病控制率(DCR)、中医症状积分、血清CA72-4、sICAM-1水平、T淋巴细胞亚群指标(CD3+、CD4+、CD8+、CD4+/CD8+)、不良反应总发生率。结果:观察组ORR、DCR均较化疗组更高(P<0.05)。观察组治疗后畏寒肢冷、脘腹胀满、恶心呕吐、神疲乏力积分均较化疗组更低(P<0.05)。观察组治疗后血清CA72-4、sICAM-1水平均较化疗组更低(P<0.05)。观察组治疗后CD3+、CD4+、CD4+/CD8+均较化疗组更高(P<0.05),CD8+较化疗组更低(P<0.05)。观察组血小板减少、贫血、脱发、恶心、呕吐总发生率与化疗组比较,差异无统计学意义(P>0.05)。结论:升阳除湿防风汤联合化疗可有效提高晚期胃癌客观缓解率、疾病控制率,缓解脘腹胀满等症状,改善免疫功能,纠正免疫失衡,降低血清CA72-4、sICAM-1表达量,且未增加不良反应发生率。
Abstract:
Objective:To analyze the clinical efficacy of Shengyang Chushi Fangfeng decoction combined with chemotherapy in the treatment of advanced gastric cancer and the changes of serum carbohydrate antigen 72-4(CA72-4)and soluble intercellular adhesion molecule-1(sICAM-1).Methods:A total of 86 patients with advanced gastric cancer were selected and divided into 2 groups with 43 cases in each group according to different treatment methods.The chemotherapy group was given conventional chemotherapy,and the observation group was given Shengyang Chushi Fangfeng decoction on the basis of chemotherapy.Objective response rate(ORR),disease control rate(DCR),TCM syndrome score,serum CA72-4,sICAM-1 levels,T lymphocyte subsets(CD3+,CD4+,CD8+,CD4+/CD8+)and total incidence of adverse reactions were compared between the two groups.Results:ORR and DCR in observation group were higher than those in chemotherapy group(P<0.05).After treatment,the scores of cold limbs,abdominal distension,nausea and vomiting and fatigue in observation group were lower than those in chemotherapy group(P<0.05).After treatment,the levels of serum CA72-4 and sICAM-1 in observation group were lower than those in chemotherapy group(P<0.05).After treatment,CD3+,CD4+,CD4+/CD8+were higher in observation group than in chemotherapy group(P<0.05),and CD8+was lower than chemotherapy group(P<0.05).The total incidence of thrombocytopenia,anemia,alopecia,nausea,vomiting in observation group was higher than that in chemotherapy group(P>0.05).Conclusion:Shengyang Chushi Fangfeng decoction combined with chemotherapy can effectively improve the objective remission rate and disease control rate of advanced gastric cancer,relieve symptoms such as epigastric distension,improve immune function,correct immune imbalance,reduce the expression levels of serum CA72-4 and sICAM-1,and do not increase the incidence of adverse reactions.

参考文献/References:

[1] FUJITA K,OMORI T,HARA H,et al.Clinical importance of carcinoembryonic antigen messenger RNA level in peritoneal lavage fluids measured by transcription-reverse transcription concerted reaction for advanced gastric cancer in laparoscopic surgery[J].Surg Endosc,2022,36(4):2514-2523.
[2] 苗青旺.进展期胃癌应用腹腔镜手术与开腹根治术的疗效对比分析[J].山西医药杂志,2020,49(2):190-192.
[3] 宋成鑫,葛信国,储晶.养阴健脾散毒法辅助化疗治疗晚期胃癌临床研究[J].陕西中医,2020,41(11):1543-1547.
[4] 陈永梅,张红,王虎.血清CA72-4、HE4、AFP、铁蛋白水平对妇科良恶性卵巢肿瘤患者的鉴别价值分析[J].川北医学院学报,2020,35(3):471-473.
[5] 强永春,李佳.经尿道膀胱肿瘤电切术后吉西他滨膀胱热灌注化疗老年浅表性膀胱癌疗效与安全性研究[J].陕西医学杂志,2021,50(2):184-187.
[6] 王茺茺,吴珊,唐梦,等.两种多西他赛联合化疗方案在局部进展期胃癌术后辅助化疗中的疗效评价[J].现代生物医学进展,2021,21(9):1696-1701.
[7] 中华医学会消化内镜学分会,中国抗癌协会肿瘤内镜专业委员会.中国早期胃癌筛查及内镜诊治共识意见(2014年,长沙)[J].中华消化内镜杂志,2014,31(7):361-377.
[8] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:233-234.
[9] 国家食品药品监督管理总局.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2002:362-363.
[10] 刘子田,王晓阳,祝新,等.白蛋白结合型紫杉醇联合奥沙利铂和替吉奥在局部不可切除的进展期胃癌转化治疗中的应用[J].中国现代普通外科进展,2021,24(5):374-377,383.
[11] 蒋峰,柳小芳,高艺文,等.解毒散结方联合化疗治疗晚期胃癌疗效及对患者血管内皮生长因子和受体的影响[J].陕西中医,2021,42(5):582-585.
[12] FANG S Q,LIU Y H,ZHAO K P,et al.Transcriptional profiling and network pharmacology analysis identify the potential biomarkers from Chinese herbal formula Huosu Yangwei formula treated gastric cancer in vivo[J].Chin J Nat Med,2021,19(12):944-953.
[13] 王巍.益气扶正解毒汤结合足三里穴位注射复方当归注射液治疗晚期胃癌患者疗效及对肿瘤标志物、免疫功能的影响[J].辽宁中医杂志,2021,48(12):129-132.
[14] 杨海宁,陈科,李爽,等.温通针刺中脘联合常规针刺对胃癌化疗后恶心呕吐的预防效果[J].辽宁中医杂志,2023,50(1):159-163.
[15] 雷永付.血清CEA、CA72-4、CA19-9、PGⅠ/PGⅡ和AFP联合检测用于食管癌早期诊断的价值分析[J].标记免疫分析与临床,2020,27(4):658-660,701.
[16] 屈慧,皇海,张蕊.血清细胞角蛋白18、骨桥蛋白水平与原发性喉癌患者临床分期相关性研究[J].陕西医学杂志,2021,50(11):1452-1456.
[17] 薛志有,张毅,倪志海.晚期结直肠癌患者应用高频热疗辅助TOMOX方案治疗前后血清sICAM-1及BAG-1蛋白水平的变化及临床意义[J].检验医学与临床,2021,18(9):1305-1307.
[18] 胡培,徐健,鲍柏军.含多西他赛联合方案治疗晚期胃癌近远期效果及对可溶性细胞间黏附因子-1和E-钙黏蛋白的影响[J].药学服务与研究,2021,21(1):37-40.
[19] 苏晓鹏,晏军,张潞潞,等.基于网络药理学探讨黄芪-丹参药对治疗肝癌的作用机制与实验验证[J].世界中医药,2022,17(24):3449-3455,3461.
[20] 陈冬梅,刘佳佳,蒙洁,等.基于lncRNA-mRNA共表达网络探讨党参增强衰老小鼠免疫功能的机制[J].中药新药与临床药理,2021,32(3):307-315.
[21] 于小刚,辛二旦,董建斌,等.白术内酯Ⅰ治疗癌症的作用机制研究现状[J].中国临床药理学杂志,2023,39(5):747-751.
[22] 张新雨,范梦月,孙蓉.基于数据挖掘及网络药理学方法探讨肝郁脾虚型功能性消化不良用药规律及机制研究[J].中草药,2021,52(14):4307-4317.
[23] 颜瀚琛,姜惟,毛可人.柴胡皂苷抗肿瘤的生物医学功能研究[J].分子植物育种,2022,20(2):689-696.
[24] 史璟,郭勇峰,常江.蛇床子素调节PI3K/AKT/MAPK信号通路对卵巢癌细胞增殖、凋亡、迁移和侵袭的影响[J].中国优生与遗传杂志,2022,30(7):1115-1119.
[25] 袁令兴,李秀峰,顾传兰,等.补骨脂素对HTB-47和CRL-1932肾癌细胞系的增殖、侵袭和迁移的影响及相关机制[J].国际生物医学工程杂志,2021,44(1):34-38.

相似文献/References:

[1]裴俊文,孙太振△,蒋立峰.基于对SGC7901细胞Survivin、Bcl2基因的调控 探讨益气化瘀散结方影响胃癌细胞增殖凋亡的作用机制*[J].陕西中医,2019,(4):411.
　PEI Junwen,SUN Taizhen,JIANG Lifeng..Study on the effect of Yiqi Huayu Sanjie decoction on the proliferation and apoptosis of gastric cancer cells based on the regulation of survivin and Bcl2 gene in SGC7901 cells[J].,2019,(6):411.
[2]高聪聪,范 筱,李 宁.益气健脾化积方对胃癌化疗疗效、患者安全性及预后影响的研究*[J].陕西中医,2019,(4):475.
[3]杨国强,闫强△.健脾解毒汤结合射频消融术治疗胃癌肝转移疗效研究[J].陕西中医,2019,(11):1510.
　YANG Guoqiang,YAN Qiang..Therapeutic effect of Jianpi Jiedu decoction combined with radiofrequency ablation on liver metastases from gastric cancer[J].,2019,(6):1510.
[4]马 婷,王品昊,朱 婕,等.行健汤联合穴位贴敷治疗进展期胃癌癌因性疲乏疗效及对患者免疫功能的影响*[J].陕西中医,2020,(10):1410.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.019]
[5]宋成鑫,葛信国△,储 晶.养阴健脾散毒法辅助化疗治疗晚期胃癌临床研究*[J].陕西中医,2020,(11):1543.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
　SONG Chengxin,GE Xinguo,CHU Jing..Advanced gastric cancer treated by the method of nourishing Yin and invigorating spleen and dispersing toxin[J].,2020,(6):1543.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
[6]周 锐,马灏川,陈亚栋,等.针灸辅助治疗胃癌现状及展望[J].陕西中医,2021,(8):1150.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.040]
　ZHOU Rui,MA Haochuan,CHEN Yadong,et al.Review of acupuncture and moxibusition on gastric cancer[J].,2021,(6):1150.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.040]
[7]孟 肖,张新庆,李 璐,等.培元益气汤改善气阴两虚证胃癌相关癌性疲乏及对患者免疫功能的影响[J].陕西中医,2023,(2):174.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.008]
　MENG Xiao,ZHANG Xinqing,LI Lu,et al.Peiyuan Yiqi decoction improves cancer-related fatigue of gastric cancer with deficiency of qi and yin and its effect on immune function[J].,2023,(6):174.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.008]
[8]苏园园,刘宁宁,赖优莹,等.胃癌中医证型研究进展[J].陕西中医,2023,(2):262.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.029]
　SU Yuanyuan,LIU Ningning,LAI Youying,et al.Progress in traditional Chinese medicine syndrome types research of gastric cancer[J].,2023,(6):262.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.029]
[9]李琳婵,鱼麦侠,郝梅梅,等.调中化湿汤对胃癌小鼠炎症损伤干预机制[J].陕西中医,2023,(3):294.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.005]
[10]熊 婷,薛川松,颜 晔.益气养血汤联合参芪扶正注射液治疗胃癌患者肿瘤相关性贫血疗效研究[J].陕西中医,2023,(8):1065.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.015]
　XIONG Ting,XUE Chuansong,YAN Ye.Effect of Yiqi Yangxue decoction combined with Shenqi Fuzheng injection on cancer related anemia in patients with gastric cancer[J].,2023,(6):1065.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.015]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(8180140119); 安徽省红十字会中医药传承创新发展研究项目(2021ZYYB08)
更新日期/Last Update: 2024-06-11